Get the Stockscreener App
24.59
0.37%
0.09
After Hours:
24.59
Precipio Inc stock is traded at $24.59, with a volume of 15,523.
It is up +0.37% in the last 24 hours and up +19.66% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$24.50
Open:
$24.85
24h Volume:
15,523
Relative Volume:
0.95
Market Cap:
$43.08M
Revenue:
$21.24M
Net Income/Loss:
$-1.80M
P/E Ratio:
-20.33
EPS:
-1.2094
Net Cash Flow:
$565.00K
1W Performance:
+16.93%
1M Performance:
+19.66%
6M Performance:
+154.16%
1Y Performance:
+316.11%
1-Day Range:
$23.67
$25.45
1-Week Range:
$20.21
$28.50
52-Week Range:
$3.90
$28.50
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
24.59 | 42.92M | 21.24M | -1.80M | 565.00K | -1.2094 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Precipio Inc Stock (PRPO) Latest News
Is Precipio Inc a good long term investmentRisk-Reward Ratio Analysis & Reduce Losses With Smart Exit Strategies - earlytimes.in
How Precipio Inc. (PRPO) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Precipio announces executive option grants tied to stock performance - MSN
Precipio, Inc. Hits New 52-Week High of $27.29, Up 356.52% - Markets Mojo
Precipio, Inc. Hits New 52-Week High of $28.50, Up 345.57% - Markets Mojo
Precipio COO Sabet buys $505 worth of shares By Investing.com - Investing.com Nigeria
Precipio COO Sabet buys $487 in company stock By Investing.com - Investing.com Australia
Precipio COO Sabet buys $487 in company stock - Investing.com
[Form 4] Precipio, Inc. Insider Trading Activity - Stock Titan
Precipio COO Sabet buys $505 worth of shares - Investing.com India
Can Precipio Inc. stock deliver sustainable ROE2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com
Precipio (NASDAQ:PRPO) & Alternate Health (OTCMKTS:AHGIF) Critical Contrast - Defense World
Can Precipio Inc. stock continue upward trendWeekly Profit Report & Consistent Return Strategy Ideas - newser.com
Why Precipio Inc. stock is favored by pension funds2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Is this a good reentry point in Precipio Inc.Quarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow - Nasdaq
What earnings revisions data tells us about Precipio Inc.July 2025 Action & Community Consensus Picks - newser.com
Historical volatility pattern of Precipio Inc. visualizedWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Precipio, Inc. (NASDAQ:PRPO) Stock Rockets 28% But Many Are Still Ignoring The Company - simplywall.st
Earnings call transcript: Precipio Q3 2025 sees strong growth and positive EBITDA - Investing.com Nigeria
Precipio Inc (PRPO) Stock Price, Trades & News - GuruFocus
Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Rev - GuruFocus
Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance UK
Precipio Reports Improved Financial Performance in Q3 2025 - TipRanks
Precipio, Inc. (PRPO) Q3 FY2025 earnings call transcript - Yahoo Finance
Can Precipio Inc. stock withstand economic slowdown2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Precipio Inc. stock daily chart insightsDollar Strength & Entry and Exit Point Strategies - newser.com
How interest rate cuts could boost Precipio Inc. stockJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
Risk vs reward if holding onto Precipio Inc.2025 Price Targets & Safe Entry Point Identification - newser.com
Precipio (NASDAQ:PRPO) Rating Lowered to “Hold” at Wall Street Zen - Defense World
Precipio Q3 2025 Earnings Call Transcript - MarketBeat
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers - MarketScreener
Precipio, Inc. Reports Strong Q3-2025 Financial Results with 30% Revenue Growth and Positive Adjusted EBITDA - Quiver Quantitative
Precipio Announces its Q3-2025 Financial Results - The Manila Times
Precipio, Inc. SEC 10-Q Report - TradingView
Precipio (NASDAQ: PRPO) posts $469K Adjusted EBITDA; $285K operating cash in Q3 - Stock Titan
[10-Q] Precipio, Inc. Quarterly Earnings Report | PRPO SEC FilingForm 10-Q - Stock Titan
Precipio Inc. stock chart pattern explained2025 Analyst Calls & Fast Entry High Yield Stock Tips - newser.com
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):